Physician
Pediatrics Reimagined LLC
Pediatrics Reimagined LLC was paid $81K by Medicaid between Jan 2024 and Dec 2024, across 13 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoPEDIATRICS REIMAGINED LLC
MANDEVILLE, LA 70448
MANDEVILLE, LA 70448
33aNPI1356123350assigned 10/16/2023
33bProvider typePediatrics Physician
28Total paid$81K
24GClaims3,595
24DCodes billed13
24AFirst – last monthJan 2024 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Louisiana
Rank by total paid#164 of 230
Median peer was paid$429K
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2024incomplete | 3,595 | $81K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 851 | 671 | $28K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 33% | 685 | 529 | $27K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 11% | 1,138 | 834 | $9K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.3% | 86 | 61 | $5K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.1% | 103 | 79 | $5K |
| H0033 | Oral medication administration, direct observation | 5.2% | 339 | 246 | $4K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 2.0% | 76 | 66 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.1% | 98 | 43 | $887.36 |
| 87807 | <1% | 46 | 39 | $406.10 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 19 | 14 | $103.70 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 38 | 33 | $5.72 |
| A9150 | Non-prescription drugs | <1% | 82 | 64 | $0.86 |
1 more codes
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 34 | $0.30 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHEARD, MICHELLE (MANAGING MEMBER)